SCHEMBL6862492

SCHEMBL6862492

COC(=O)CCc1cc(-n2nc3ccc(Cl)cc3n2)c(O)c(C(C)(C)c2ccc(Cl)cc2)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.38
EGFR P00533 1/20 0.38
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
TBXAS1 P24557 1/20 0.35
RXFP1 Q9HBX9 1/20 0.34
MAPT P10636 3/20 0.34
TP53 P04637 1/20 0.34
ALDH1A1 P00352 3/20 0.33
ADORA3 P0DMS8 2/20 0.33
LMNA P02545 1/20 0.33
CNR1 P21554 1/20 0.33
GAA P10253 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
CYP2C19 P33261 1/20 0.33
POLB P06746 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5835062 0.95 KDM4E (0.42) KDM4EEGFRCYP11B1CYP11B2TBXAS1
SCHEMBL78795 0.91 GAA (0.42) KDM4EEGFRCYP11B1CYP11B2ALDH1A1
SCHEMBL29664175 0.91 GAA (0.42) KDM4EEGFRCYP11B1CYP11B2ALDH1A1
SCHEMBL1896797 0.88 MAOB (0.42) KDM4EEGFRCYP11B1CYP11B2ALDH1A1
SCHEMBL7521604 0.87 KDM4E (0.42) KDM4EEGFRCYP11B1CYP11B2TBXAS1
SCHEMBL6863921 0.86 EPHX2 (0.39) ALDH1A1CNR1HPGD
SCHEMBL5834041 0.85 KDM4E (0.38) KDM4ETBXAS1TP53ALDH1A1ADORA3
SCHEMBL13546033 0.85 KDM4E (0.35) KDM4EALDH1A1LMNAGAAMAOA
SCHEMBL29142799 0.84 KDM4E (0.47) KDM4EEGFRCYP11B1CYP11B2TBXAS1
SCHEMBL6864209 0.84 KDM4E (0.39) KDM4ECYP11B1CYP11B2MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6800676-B2 ULTRAVIOLET RADIATION ABSORBERS; HEAT AND OXIDATION RESISTANCE CIBA SPECIALTY CHEMICALS CORPORATION 2004-10-05 US disclosed
EP-1305297-A1 BENZOTRIAZOLES CONTAINING ALPHA-CUMYL GROUPS SUBSTITUTED BY HETEROATOMS AND COMPOSITIONS STABILIZED THEREWITH Ciba SC Holding AG (CH) 2003-05-02 EP disclosed
US-20030004235-A1 Benzotriazoles containing phenyl groups substituted by heteroatoms and compositions stabilized therewith CIBA SPECIALTY CHEMICALS CORP. 2003-01-02 US disclosed
US-6451887-B1 Benzotriazoles containing α-cumyl groups substituted by heteroatoms and compositions stabilized therewith CIBA SPECIALTY CHEMICALS CORPORATION 2002-09-17 US disclosed
WO-2002012205-A1 BENZOTRIAZOLES CONTAINING α-CUMYL GROUPS SUBSTITUTED BY HETEROATOMS AND COMPOSITIONS STABILIZED THEREWITH CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2002-02-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030004235-A1 Benzotriazoles containing phenyl groups substituted by heteroatoms and compositions stabilized therewith SUV39H1, SUV39H2, TPST2 KDM4E 343/4885EGFR 4698/4885CYP11B1 3230/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.